Comparison of pan-immune-inflammation value with other inflammation markers of long-term survival after ST-segment elevation myocardial infarction.
Bektas MuratSelda MuratMehmet OzgeyikMuzaffer BilginPublished in: European journal of clinical investigation (2022)
Our study reveals that PIV is a better predictor of mortality in STEMI patients. Prospective studies are needed to validate this biomarker.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- end stage renal disease
- oxidative stress
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- st elevation myocardial infarction
- coronary artery disease
- cardiovascular events
- type diabetes
- patient reported outcomes